Debt-to-equity of Denali Therapeutics Inc. from 30 Sep 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Denali Therapeutics Inc. quarterly Debt-to-equity in % history and change rate from 30 Sep 2018 to 30 Sep 2025.
  • Denali Therapeutics Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 13%, a 36% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Denali Therapeutics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 13% +3.4% +36% 30 Sep 2025
Q2 2025 12% +2.4% +25% 30 Jun 2025
Q1 2025 11% +0.62% +6.1% 31 Mar 2025
Q4 2024 9.7% -9% -48% 31 Dec 2024
Q3 2024 9.6% -16% -62% 30 Sep 2024
Q2 2024 9.7% -25% -72% 30 Jun 2024
Q1 2024 10% -35% -78% 31 Mar 2024
Q4 2023 19% -26% -59% 31 Dec 2023
Q3 2023 25% -21% -45% 30 Sep 2023
Q2 2023 35% -9.9% -22% 30 Jun 2023
Q1 2023 45% +2.1% +4.9% 31 Mar 2023
Q4 2022 45% +2.6% +6.2% 31 Dec 2022
Q3 2022 47% +5.9% +14% 30 Sep 2022
Q2 2022 45% +8.6% +24% 30 Jun 2022
Q1 2022 43% +9.6% +28% 31 Mar 2022
Q4 2021 42% +12% +39% 31 Dec 2021
Q3 2021 41% +13% +48% 30 Sep 2021
Q2 2021 36% +3.2% +9.8% 30 Jun 2021
Q1 2021 34% -0.55% -1.6% 31 Mar 2021
Q4 2020 30% -5% -14% 31 Dec 2020
Q3 2020 28% -2.9% -9.4% 30 Sep 2020
Q2 2020 33% +6.9% +26% 30 Jun 2020
Q1 2020 34% +12% +57% 31 Mar 2020
Q4 2019 35% +18% +103% 31 Dec 2019
Q3 2019 30% +17% +128% 30 Sep 2019
Q2 2019 26% 30 Jun 2019
Q1 2019 22% 31 Mar 2019
Q4 2018 17% 31 Dec 2018
Q3 2018 13% 30 Sep 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.